1. | hunter594090 | |
2. | gil3of87998 | |
3. | dafferdoo | |
4. | aben0719 | |
5. | watasiba4502 |
1. | hunter594090 | |
2. | gil3of87998 | |
3. | dafferdoo | |
4. | aben0719 | |
5. | watasiba4502 |
1. | gil3of87998 05/30/2018 Mustang Bio Announces Preclinical Data on Potency of its CAR T Cells in Glioblastoma Published in JCI Insight |
2. | gil3of87998 01/02/2018 Avenue Therapeutics Announces Dosing of First Patient in Phase 3 Safety Trial |
3. | hunter594090 03/14/2018 Fortress Biotech to Present at Oppenheimer's 28th Annual Healthcare Conference |
4. | hunter594090 03/16/2018 Fortress Biotech Reports Fourth Quarter and Full-Year 2017 Financial Results and Recent Corporate Highlights |
5. | gil3of87998 03/01/2018 Avenue Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Recent Corporate Highlights |
6. | hunter594090 07/02/2018 Fortress Biotech Announces Cyprium Therapeutics' CUTX-101 (Copper Histidinate) Granted FDA Fast Track Designation for Treatment of Classic Menkes Disease |
7. | gil3of87998 03/30/2018 Mustang Bio Reports Fourth Quarter and Full-Year 2017 Financial Results and Recent Corporate Highlights |